Skip to content

Veracyte VCYT Net Change in Cash

Net Change in Cash at other companies

Guardant Health logo
Guardant HealthGH
$612.02M+252%
Natera, Inc. logo
Natera, Inc.NTRA
$11.79M-58.2%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$23.2M-170%
Revvity logo
RevvityRVTY
-$59.56M-131%
Labcorp Holdings logo
Labcorp HoldingsLH
$448.8M+139%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$27M+92.5%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's net change in cash?
Veracyte (VCYT) reported net change in cash of -$99.43M in Q1 2026.
How has Veracyte's net change in cash changed year-over-year?
Veracyte's net change in cash decreased by 88.1% year-over-year, from -$52.87M to -$99.43M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.